2008 2007 2008 2007
Net sales $18,112 $13,629 $56,737 $43,478
Cost of sales 7,654 6,859 26,990 22,176
Gross profit 10,458 6,770 29,747 21,302
General and administrative: 3,480 2,868 11,441 9,581
Marketing and selling 6,514 5,775 20,627 17,223
Research and development 1,890 1,743 5,965 4,987
Loss on settlement of pre-existing
distribution arrangement - - 3,850 -
Total selling, general and
administrative expenses: 11,884 10,386 41,883 31,791
Operating loss (1,426) (3,616) (12,136) (10,489)
Other expense, net (585) (409) (706) (880)
Loss before provision (benefit) for
income taxes (2,011) (4,025) (12,842) (11,369)
Income tax provision (benefit) 239 (195) 893 339
Net loss $(2,250) $(3,830) $(13,735) $(11,708)
Basic and diluted loss per share $(0.08) $(0.13) $(0.47) $(0.42)
Weighted average shares outstanding 29,490 29,374 29,489 27,993
STAAR Surgical Company
Global Sales
(in 000's)
Unaudited
Three Months Ended Nine Months Ended
September September September September
26, 28, 26, 28,
Geographic Sales 2008 2007 % Change 2008 2007 % Change
United States $4,746 $4,739 0.1% $14,468 $14,991 -3.5%
Germany 5,844 5,742
'/>"/>
| SOURCE STAAR Surgical Company Copyright©2008 PR Newswire. All rights reserved |